By Leonard Lerer, Mike Piper
This ebook is a accomplished evaluation of the present country of electronic innovation, net task, and e-business within the existence sciences area and a pragmatic consultant for managers making plans, constructing, and enforcing e-strategies within the pharmaceutical undefined. The authors supply various examples of leading edge, top perform and lay the strategic origin for utilizing e-business around the pharmaceutical price chain from drug discovery to general practitioner promoting to direct-to-consumer advertising.
Read Online or Download Digital Strategies in the Pharmaceutical Industry PDF
Similar nonfiction_5 books
How to imagine and interact like a scientist! BIOLOGY: THE DYNAMIC technology, moment version, offers you a deep knowing of the middle thoughts in Biology, construction a robust beginning for extra research. In a clean presentation, the authors clarify complicated rules essentially and describe how biologists gather and interpret facts to check hypotheses concerning the residing global.
Gautama was once born a prince, over 2500 years in the past in Lumbini, within the northern a part of India. He left the cozy lifetime of the palace, his younger spouse and boy or girl son, to move looking for actual wisdom. After a lifetime of wandering, austerities and meditation, he turned Buddha ('the Enlightened one'). Buddha taught compassion, non-violence and the necessity for correct behavior in existence.
Quantity 1 of three of a set of non secular discourses through Shri Atmananda (Krishna Menon, 1883-1959), a dwelling consultant of the culture of Advaita Vedanta and one of many nice sages of the fashionable international. The discourses have been recorded throughout the interval of 1950 to 1959 via a depended on disciple. they're brief and masterful talks on knowing the reality via a popularity that our nature is usually natural attention.
- The Low GI Shopper's Guide to GI Values 2011: The Authoritative Source of Glycemic Index Values for 1200 Foods by Dr. Jennie Brand-Miller (2011-05-10)
- Modeling, Design, and Simulation of Systems with Uncertainties
- Rugby For Dummies (For Dummies (Sports & Hobbies))
- Company Law: Fundamental Principles by Stephen Griffin (2005-11-14)
Extra info for Digital Strategies in the Pharmaceutical Industry
Six Paracel GeneMatchers (each with thousands of processors – Paracel is a massively parallel processor manufacturer that Celera purchased last year). ■ Additionally, an agreement between Celera and Sandia National Laborator y will develop a supercomputing platform for mining and modelling genetic data. The $25 million project will be powered by multiple Compaq AlphaServers and is expected to provide 100 trillion operations per second (Teraops) of raw computer power, making it the world’s largest supercomputer .
This is a demanding but high-value market. The demanding requirements of the biosciences IT market ■ Hardware. High-end servers and supercomputers, networking gear, workstations and instrumentation. ■ Storage. In the order of petabytes. ■ Services. Hosting and application provision services for decoding genomes and analysing their functions. ■ Software. Knowledge management, database systems, and applications for informatics, sequencing, proteomics, computational chemistr y, visualization and much more.
Current drug pipelines will not meet growth expectations, especially as double-digit profit growth has been the norm. To meet this ambitious target, Pfizer would have to release three $1 billion blockbusters a year from 2003. From 2007, when key patents expire, it would have to release seven. Historically, the combined Pfizer and Warner-Lambert pipelines have produced fewer than two new drugs a year in the past ten years, few of which have been blockbusters . 1 R&D expenses as a percentage of sales – US-based pharmaceutical firms Source: Based on  therapeutic areas, and the industry faces increased pricing scrutiny from payers concerned about a perceived lack of innovation; two-thirds of the prescription drugs approved by the FDA between 1989 and 2000 were identical to or modified versions of existing drugs .